SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-021893
Filing Date
2015-04-08
Accepted
2015-04-08 19:51:31
Documents
2
Period of Report
2015-04-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v406915_3.html 3  
1 OWNERSHIP DOCUMENT v406915_3.xml 3 1608
2 EXHIBIT 24.1 v406915_ex24-1.htm EX-24.1 7836
  Complete submission text file 0001144204-15-021893.txt   10894
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KINETIC CONCEPTS, INC 8023 VANTAGE DRIVE SAN ANTONIO TX 78230
Business Address
Carbeau Mark B (Reporting) CIK: 0001339155 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 15760144